Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Braslyn Ltd.

Q3 2024 · 13F-HR

Braslyn Ltd.holdings as filed

Filed 2024-11-14 · accession 0000895345-24-000581

$12.6M
Reported value
2
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
45782B302INSGINSEEGO CORP$12.4M98.4%761,483CommonSOLE
87583X109TNGXTango Therapeutics Inc.$207,6001.64%26,961CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.